What is a Good Annual Rate of Return?
Understand how to evaluate investment returns, discount rates, and what realistic expectations look like for long-term value investing.
Should you buy Flexion Therapeutics stock? (NasdaqGM:FLXN). Let's see how it does in our automated value investing analysis system.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold Flexion Therapeutics to reach your target.
| Advantages | Disadvantages | Neutral |
|---|---|---|
|
|
|
| FLXN Price (Flexion Therapeutics stock price per share) |
$25.39 | |
| PE Ratio versus Sector | 100% lower than other Healthcare stocks | |
| PE Ratio versus Industry | 0% lower than other Drug Manufacturers - Specialty & Generic stocks | |
| Free Cash Flow Jitter | 27% |
Understand how to evaluate investment returns, discount rates, and what realistic expectations look like for long-term value investing.
Learn when dividend yields signal opportunity versus risk, and how to evaluate dividend sustainability in your portfolio.
Master the methods for projecting company growth rates and earnings, essential for calculating intrinsic value with confidence.
Based on our analysis, we believe that you should not buy Flexion Therapeutics right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Advertisement supports free stock analysis content.
Does Flexion Therapeutics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
This example shows how we apply the Trendshare checklist to FLXN: earnings power, cash generation, valuation, and margin of safety.
We check: business quality, free cash flow, P/E, and margin of safety.